...
首页> 外文期刊>Antimicrobial agents and chemotherapy. >Does the activity of the combination of imipenem and colistin in vitro exceed the problem of resistance in metallo-beta-lactamase-producing Klebsiella pneumoniae isolates?
【24h】

Does the activity of the combination of imipenem and colistin in vitro exceed the problem of resistance in metallo-beta-lactamase-producing Klebsiella pneumoniae isolates?

机译:亚胺培南和粘菌素的体外组合活性是否超过产生金属β-内酰胺酶的肺炎克雷伯菌分离株的抗药性?

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Using time-kill methodology, we investigated the interactions of an imipenem-colistin combination against 42 genetically distinct Klebsiella pneumoniae clinical isolates carrying a bla(VIM-1)-type gene. Irrespective of the imipenem MIC, the combination was synergistic (50%) or indifferent (50%) against colistin-susceptible strains, while it was antagonistic (55.6%) and rarely synergistic (11%) against non-colistin-susceptible strains (with synergy being observed only against strains with colistin MICs of 3 to 4 microg/ml). The combination showed improved bactericidal activity against isolates susceptible either to both agents or to colistin.
机译:使用时间杀灭方法,我们调查了亚胺培南-colistin组合对42种携带bla(VIM-1)型基因的遗传学上不同的肺炎克雷伯菌的相互作用。不管亚胺培南MIC如何,该组合对大肠菌素敏感株均具有协同作用(50%)或无关紧要(50%),而对非科氏素敏感株(具有阿司匹林敏感性)则具有拮抗作用(55.6%),很少具有协同作用(11%)。仅针对大肠菌素MIC为3至4微克/毫升的菌株观察到协同作用。该组合显示出对对两种药剂或粘菌素均敏感的分离株的杀菌活性提高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号